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1. Introduction 
Sleep disturbances are extremely common among dialysis patients. Subjective sleep 
complaints are reported in up to 80% of patients and are characterized by difficulty in 
initiating and maintaining sleep, problems with restlessness, jerking legs, snoring, choking 
sensations and/or daytime sleepiness (Holley et al., 1992; Walker et al., 1995; Veiga et al., 
1997). Epidemiological studies have found how sleep apnea syndrome (SAS), restless legs 
syndrome (RLS) and periodic limb movement disorder (PLMD) are much more prevalent than 
in the general population. These sleep problems appear to have significant negative effects on 
the quality of life as they are often cited as major sources of stress. Indeed, interviews of 
patients on hemodialysis and on peritoneal dialysis have found that sleep disturbances are one 
of the seven most distressing symptoms experienced (Eichel et al., 1986; Bass et al., 1999). Half 
of patients complaining of sleep disturbances feel that these problems affect their daily living 
and activity, and 21% consider that relief of this symptom would improve significantly their 
subjective quality of life (Parfrey et al., 1988; Iliescu et al., 2003).   
In the following sections two major sleep disturbances associated with Insomnia, Restless Legs 
Syndrome and Sleep Apnea Syndrome, will be reviewed in detail.  
2. Sleep disturbances among dialysis patients 
2.1 Insomnia 
Insomnia, one of the major causes of sleep disturbances, is defined by the presence of difficulty 
in falling asleep, frequent awakenings with difficulty in falling asleep again and early morning 
awakenings. In order to be considered an insomniac, these symptoms should be reported at 
least 3 times per week and the presence of resultant daytime dysfunction should be 
investigated in order to distinguish two levels of insomnia (level 1, without daytime 
dysfunction, and level 2, with daytime dysfunction) (Ohayon et al., 1996). Insomnia should be 
distinguished in primary and secondary insomnia. Secondary forms of insomnia can be the 
consequence of internal medical disturbances but also of other sleep disturbances such as RLS 
and SAS, which will be further reviewed in detail. Insomnia is primarily a clinical diagnosis 
and is most frequently diagnosed using data obtained from patient histories and sleep diaries. 
The prevalence estimates of insomnia vary because of differences in definition, diagnosis, 
population characteristics, and research methodologies. Its prevalence in the general 
population ranges from 4% to 64% (Ohayon et al., 2002, Chevalier et al., 1999).  
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The assessment of sleep disturbances can be done through sleep questionnaires (i.e. 
Pittsburgh Quality Index– PSQI) aimed to evaluate subjectively these disorders, or through 
polysomnographic measures, able to offer an objective analysis of sleep disturbances. The 
latter would also have a role in the diagnosis of SAS or periodic limbs movements and for 
the objective characterization of macro or micro alterations of sleep architecture in insomnia.    
Many studies have been conducted up to now in order to assess the prevalence of sleep 
complaints among dialysis patients. Prevalence rates of subjective sleep complaints vary 
among studies due to the different methodological approaches (e.g. modalities of interview, 
type of questionnaires, definition of inclusion criteria, etc.) and sample sizes.  
The prevalence of insomnia among dialysis patients is greater than the general population, 
rates up to 70% have been reported (Sabbatini et al., 2002; Iliescu et al., 2003; Merlino et al., 
2006). The earliest study to have evaluated the prevalence of subjective sleep complaints 
among dialysis patients was conducted in 1982 (Strub et al., 1982). They found that 63% of 
patients reported sleep disturbances characterized by diminished, fragmented sleep and 
increased wake time after sleep onset. Similar data were found by a study of Holley et al. in 
which the most common complaints included trouble falling asleep (67%), nighttime 
awaking (80%), early morning awaking (72%), restless legs (83%), and jerking legs (28%). 
Daytime sleepiness was common and dialysis patients reported napping for periods 
averaging 1.1+1.3 h per day (Holley et al., 1992). After these pioneer studies many others 
have addressed on this topic and have found similar prevalence rates.  A recent study from 
20 Italian dialysis centers, showed the prevalence of insomnia, RLS, and symptoms 
suggestive of SAS to be 69.3%, 18%, and 27%, respectively (higher than in the general non-
renal population) (Merlino et al., 2006). 
Most of these studies have also looked for a correlation between sleep complaints and 
numerous demographic, clinical, and laboratory data. Sleep complaints seem to be more 
common in elderly patients on dialysis than in younger patients (Kutner et al., 2001; Walker 
et al., 1995). It has been reported that each decade of age increases the risk of insomnia 
(subclinical and clinical) by 239% and the risk of overt clinical insomnia by 51% (De Santo et 
al., 2005). The effect of gender on sleep quality is controversial. It has been found that male 
patients are more likely to have sleep complaints than female patients, even though women 
report using more sleep medications than men (Kutner et al., 2001; Walker et al., 1995). 
White patients have a higher prevalence of restless sleep than blacks  (Walker et al., 1995). 
Positive relationship between subjective sleep complaints and caffeine intake and cigarette 
use has also been reported (Holley et al., 1992). Increased stress, anxiety, depression and 
worry, as observed also in the general population, are associated with poor subjective sleep 
quality in dialysis patients (Holley et al., 1992; Kutner et al., 2001; Parker et al., 1996). 
Depression seems to be the primary mental health problem in this group of patients. 
Dialysis patients with sleep disturbances have a prevalence of depression of 20% (Iliescu et 
al., 2003).  The use of sleep ipnotic medications among dialysis patients is about 8-10% (De 
Santo et al., 2001; 2005).  
Concerning laboratory data, one study has reported that improvement of anemia leads to 
amelioration of sleep quality, reduction of nighttime awakenings and reduction of sleep 
fragmentation. Thus, a more efficient sleep is obtained, leading to a decreased daytime 
somnolence (Ohayon et al., 1997). Other previous studies have shown how low levels of Hb 
are associated with a deteriorated sleep quality (Kusleikaite et al., 2005; Iliescu et al., 2003; 
Benz et al., 1999). However, this situation is controversial and is not confirmed by all 
studies. Other studies assessing an association between sleep disturbances in peritoneal 
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dialysis patients and Hb levels have failed to show such an association (Walker et al., 1995; 
Holley et al., 1992; Stepanski et al., 1995). No consistent relationships have been found 
between subjective sleep complaints and laboratory measures of renal failure (blood urea 
nitrogen-BUN, creatinine) and parameters of dialysis efficacy (Kt/V) (Puntriano et al., 1999; 
Holley et al., 1992; Walker et al., 1995). Only a small study by Millman et al., has reported a 
significant relationship between sleep apnea and azotemia (Millman et al., 1985).  
A correlation between the type and the duration of dialysis has also been searched. No 
difference has been found between hemo (HD) and peritoneal dialysis (PD). Both of them, 
indeed, are associated with a high rate of poor sleep quality (Eryavus et al., 2008). A 
relationship with the dialysis vintage has been found. It appears that, the longer the dialysis 
vintage, the higher the prevalence of sleep disturbances. In an Italian study, those patients 
on dialysis who presented sleep disturbances had a double dialysis vintage when compared 
to those on dialysis who did not have sleep problems (De Santo et al., 2005). When 
analyzing the timing of dialysis shifts, a higher rate of insomnia has been reported among 
patients on the morning dialysis shift. In fact, compared to patients receiving their dialysis 
in the afternoon, subjects treated in the morning show a significantly higher risk of being 
affected by insomnia (p<0.001) (Merlino et al., 2006). However these results have not been 
confirmed. In fact, a later study by Eryavuz et al. has found a higher rate of insomnia among 
patients on the afternoon shift. Regarding dialysis duration, results seem to be controversial 
as well. Only some studies have reported an association between longer dialysis duration 
and insomnia (Sabbatini et al., 2001;  Veiga et al., 1997). In particular, higher PSQI scores 
have been found among patients who have received HD for a long period of time. Whereas, 
a positive correlation has also been found with a premature discontinuation of dialysis. 
Recently literature has focused the attention on inflammatory markers. It has been 
demonstrated indeed, how they can be increased in sleep disorders with normal renal 
function or in end stage renal disease (ESRD) patients. Subsequently persistent elevation of 
these markers is associated with many clinically important complications, including 
atherosclerosis and cardiovascular mortality. These findings, together with the finding of a 
poorer sleep quality independently linked to higher mortality rate among ESRD patients, 
has led to the search of an association between inflammatory markers in ESRD and poor 
sleep quality. A recent study has shown that higher systemic inflammation, as demonstrated 
by serum hsCRP and IL-1┚ levels, is associated with poorer sleep quality in stable HD 
patients. Other inflammatory markers, such as IL-6 and TNF-┙, are also positively correlated 
with poorer sleep quality; even though these results did not reach statistical significance 
(Yen-Ling Chiu et al., 2009). 
Polysomnographic studies of this population have found how sleep macrostructure can be 
altered. The earliest studies are reported in the late 1960s and early 1970s. These reports 
described sleep as being characterized by decreased total sleep time, irregular sleep cycles, 
and long periods of interspersed waking (Reichenmiller et al., 1971; Passouant et al., 1970). 
Recent studies have confirmed a sleep characterized by short duration and fragmentation 
with sleep efficiencies ranging between 66% and 85%, long periods of wake time after sleep 
onset (77±135 min), and frequent arousals (25±30/h of sleep) (Parker et al., 2003). The 
macrostructural analysis has shown an increase of Stage 1 and 2 and a decrease of slow 
wave sleep (SWS) and REM sleep (Wadhwa et al., 1992; Parker et al., 2003; Stepanski et al., 
1995). Parker et al has conducted a polysomnographic study on HD patients and has 
observed that these patients have a total sleep time and sleep efficiency significantly 
reduced compared to the general population, while, in comparison with patients affected by 
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chronic kidney disease but not undergoing dialysis therapy, they have a significantly higher 
brief arousal index (Parker et al., 2005).  
The presence of insomnia among dialysis patients has led to the hypothesis that kidney 
transplant, by restoring renal function and alleviating many uremic symptoms, might also 
reduce sleep complaints. A cross sectional study, has used the Athens Insomnia Scale to 
assess the prevalence of insomnia in a large sample of kidney transplant recipients 
compared with wait-listed dialysis patients and also a matched group obtained from a 
nationally representative sample of the Hungarian population. Authors found that the 
prevalence of insomnia was lower among kidney transplant patients than among those on 
dialysis (Novak et al., 2006). 
2.2 Excessive Daytime Sleepiness 
Excessive daytime sleepiness (EDS), the major daytime consequence of sleep disturbances, 
has also been assessed among dialysis patients. EDS is defined by the inability to stay awake 
and alert during the major waking periods of the day, resulting in unintended lapses into 
drowsiness or sleep. Prevalence of EDS can be assessed subjectively, by standardized 
questionnaires, or objectively, by Multi Sleep Latency Test (MSLT). Most studies prefer to 
use subjective scales. Prevalence of EDS in patients ongoing dialysis therapy varies between 
12% and 67% (Mucsi et al 2004, Merlino et al 2006, Hanly et al, American Accademy of sleep 
medicine). This large variability may be explained by different sample size and cut-off 
scores to indicate pathological sleepiness. 
Parker et al. showed that 32,6 % of hemodialyzed patients had MSLT score < 8 minute and 
13% < 5 minutes. MSLT scores were negatively correlated with respiratory disturbances (P= 
0,028) and brief arousals (p=0,009). Metabolic parameters and sleep apnea seemed to 
directly or indirectly influence daytime sleepiness (Parker et al. 2003).   Hanly et al. reported 
that MSLT score was negatively correlated to blood urea nitrogen, a marker of renal 
function, (r= -0,58; p=0,008. These studies hypothesized some possible mechanisms able to 
explain the presence of EDS. First, dialyzed patients frequently receive multiple 
medications, some of which can have sedative effects. Second, sleep apnea and sleep 
fragmentation, typical among dialyzed patients, can be associated with EDS. Third, renal 
function might affect the ability to stay awake, due to uremic encephalopathy, elevations of 
parathyroid hormone and abnormalities in neurotransmitter synthesis. Fourth, 
inflammatory cytokines may be released following stimulation of neutrophiles by the 
dialyzing membrane, which may have sleep inducing properties.   
2.3 Restless legs syndrome 
Restless legs syndrome is a common neurological disorder that is characterized by an urge 
to move the legs (rarely also the arms) and peculiar unpleasant sensations deep in the legs. 
Sensations appear during periods of rest or inactivity , particularly in the evening and at the 
night , and are tipically relieved by movements. Prevalence of RLS in general population 
ranges between 3 and 5%; RLS may occur as an idiopathic form or secondary to other 
conditions; the main secondary forms are iron deficiency, pregnancy , use of drugs and 
kidney disease. The association has been described for other diseases, among them, for 
diabetes (Merlino et al., 2007; Lopes et al., 2005) and multiple sclerosis (Italian REMS Study 
Group). RLS secondary to end stage renal disease is one of the most important secondary 
forms. In the past most of the studies have analyzed only hemodialysis. However,  recently  
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there is an increasing interest on the pre-dialytic phase of kidney disease and on the 
peritoneal dialysis.  
The prevalence of RLS in patients undergoing dialysis varies widely, from 12% to 57,4% 
(Takaki et al., 2003; Walker et al., 1995). This large variability is due to the heterogeneity of the 
study population and to the different criteria used to diagnose RLS. Pathophysiology of RLS in 
ESRD is still unclear. Some studies have suggested a possible role of anemia. In a study with 
55 dialyzed patients, authors found RLS’s symptoms in 40 % of patients and showed that 
RLS’s patients had lower hemoglobin values compared to others dialyzed patients (P=0,03). 
Same authors subsequently demonstrated that symptoms in this group of patients improved 
with the correction of anemia with epoetin alfa (Roger et al., 1991). The role of 
calcium/phosphate in the pathogenesis of RLS has also been hypothesized. In a study with 
136 dialyzed patients, with a prevalence of RLS of 23%, there were no significant differences 
between the two groups, except for intact parathyroid hormone (iPTH). Uremic patients with 
RLS showed a significantly lower iPTH (p< 0,01) concentration (Collado Seidel V et al., 1998). 
However, this hypothesis has not been confirmed by other studies. Successful renal 
transplantation has immediate dramatic effects on uremic RLS.  In a study including 11 
patients with a long term course of RLS symptoms, they all had a complete recovery within 1 
to 21 days after a kidney transplantation. Whereas, among those patients who again became 
dependent on dialysis due to a chronic transplant failure, RLS symptoms reoccurred within a 
few days after restarting hemodialysis. (Wilkelmann et al., 2002).  In 2005 Molnar et al showed 
that RLS’s symptoms were less frequent in patients after kidney transplantation than in 
patients undergoing dialysis therapy. Thus, authors suggested that “uremic factors “, 
responsible for the higher prevalence of RLS in dialysis patients, are largely eliminated after a 
successful kidney transplantation (Molnar et al., 2005).  Differently from transplantation, 
dialysis did not show any positive effect on RLS. Indeed, studies reported that frequency of 
dialysis session per week and dialysis dependency, are higher in uremic patients with RLS 
than in those without it (Gigli et al., 2004; Huiqi et al., 2000). Several observations have 
suggested an association between RLS and neuropathy, especially with involvement of small 
sensory fibers. In fact, abnormal hyperexcitability of spinal circuits in RLS could be induced 
not only by impaired descending dopaminergic modulation, but also by changes in the spinal 
cord itself (Paulus et al., 2007) or by abnormal inputs as found in peripheral nervous system 
(PNS) diseases (Gemignani et al., 2006).  In general, prevalence estimates of RLS in neuropathy 
of any kind are extremely variable, ranging from 5.2% to 54% (Rutkove et al., 1996; Nineb et 
al., 2007). The occurrence of symptoms of burning feet suggested a prominent role of C fibers, 
assuming that receptors are hyperexcitable due to irritative changes in unmyelinated fibers 
conveying hot sense (Lacomis, 2002; Ochoa et al., 2005; Ørstavik et al., 2006). Alternatively, 
abnormal thermal sensations may be produced by impaired central integration of information 
from nociceptive and thermal channels, as suggested by paradoxical heat sensation produced 
by A-delta fiber deafferentation (Susser et al., 1999). In accordance with previous data 
suggesting that RLS occurs preferentially in sensory polyneuropathy of mild to moderate 
degree and/or in early phase (Iannaccone et al., 2000), patients with RLS had less severe 
changes in SAPs. This pathogenetical mechanism could explain, at least partially, the 
association between RLS and ESRD.  
There is a lack of studies about prevalence of RLS in patients undergoing PD. Personal 
preliminary observations suggest that PD patients might have a lower prevalence of RLS 
than HD patients but higher than “pre-dialysed” patients, with characteristics which 
resemble more to those of idiopathic forms than of secondary forms. These aspects confirm 
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the possible role of hemodialysis in causing RLS.  RLS symptoms in dialysis are severe and 
have a negative impact on quality of life and increase the risk of mortality in this specific 
population. In particular, different studies have showed a correlation between RLS and an 
increased cardiovascular risk. In particular, periodic limb movements during sleep induce 
rises in blood pressure, which may play a role in the pathogenesis of cardiovascular diseases 
(Winkelman et al., 2008). Another possible mechanism is that sleep deprivation, tipically 
found in patients with severe forms of RLS, can increase inflammatory markers. A persistent 
and chronic increase of inflammatory markers can be associated with and increased cardio 
and cerebrovascular risk.  
2.4 Sleep apnea syndrome 
Sleep apnea syndrome (SAS) is characterized by disordered breathing during sleep, 
resulting in heavy snoring, repetitive apnea, restless sleep, fragmented sleep structure, 
morning headache, and daytime sleepiness. Often SAS is associated with personality and 
mood change such as depression. The following types of apnea can be distinguished: i- 
obstructive apnea ii- central apnea iii-mixed apnea. Obstructive sleep apnea syndrome is 
characterized by repetitive closures of the upper airways during sleep, usually at the 
pharyngeal level, which produce apneas, increasing respiratory effort against the collapsed 
airways inducing repetitive arousals. Central sleep apnea is characterized by unstable 
decrease or even absent regulatory motor activity of the respiratory centers in the central 
nervous system during sleep, leading to apneic episodes.  Most central apneas occur at sleep 
onset. They are characterized by a cycle of decreased or absent respiratory effort or absent 
respiratory effort and are terminated by ongoing arousals.  Apneic episodes lead to 
microarousals determining a fragmentation of sleep and the activation of sympathetic 
nervous system. 
Studies have reported a high prevalence of SAS in patients with chronic kidney disease. 
Compared with the general population where the prevalence of SAS is estimated to be 2-4%, 
prevalence in the ESRD population appears to be 30% or more (Kuhlmann et al. 2000; Young 
et al. 1993; Kimmel et al. 1989). This is partly explained by the fact that the most common 
comorbid conditions of ESRD, such as atherosclerosis and diabetes, are also independently 
associated with ESRD.  Among dialysis patients, central and obstructive sleep apnea are 
almost equally observed, whereas, in the general population the prevalence of obstructive 
sleep apnea is higher.  A mechanism able to cause both destabilization of central ventilator 
and upper airway obstruction has been suggested. Indeed, central events could be due to 
metabolic acidosis that may change the apnea PCO2 threshold and consequently destabilize 
respiratory control. In addition, dialyzed patients show an accumulation of uremic toxins 
and endogenous opioids that may result in an unstable breathing pattern. Other factors that 
can worsen SAS in dialysis are: i- the central uremic neuropathy that might reduce airway 
muscle tone during sleep or destabilize respiratory control; ii- edema from fluid overload 
that tend to favor upper airway collapse; iii- elevated values of several cytokines (observed 
during dialysis) that can influence sleep (Vgontzas et al. 2000).  Sleep apnea syndrome is 
frequent both in HD and in PD. In past studies, it was not found a significant difference 
between these two types of dialysis for sleep apnea. Studies have found that nocturnal 
peritoneal dialysis (NPD) seems to improve SAS. In a study, Tang et al. recruited 23 NPD 
patients and 23 Continuous ambulatory peritoneal dialysis (CAPD) patients. The prevalence 
of sleep apnea with AHI > 15 was 52 % for NPD and 91% for CAPD. Bioelectrical impedance 
analysis revealed that total body water (TBW) content was significantly lower during NPD 
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than CAPD (32,8 L vs 35,1 L; p< 0,004).  Probably, the improvement of sleep apnea by NPD 
is due to the improved extracellular fluid control during sleep (Tang et al. 2006).  
Similar to nocturnal haemodialysis, improved clearance of uremic toxins after successful 
kidney transplant would be expected to alleviate SAS, but the relationship between SAS and 
renal transplant can be viewed as a paradox. In fact, although renal transplant can 
potentially improve SAS in the dialysis population, the post-transplant state may add 
another risk for SAS, specifically by predisposing patients to the metabolic syndrome. The 
prevalence of SAS among renal transplant patients is comparable with the dialysis 
population: in a study with a population of 1037 kidney transplant patients and 175 patients 
wait-listed for transplant, 27% of transplant patients had a high risk of SAS that was 
comparable with 33% in the wait-listed group (Molnar et al. 2007). The possible mechanism 
that can cause SAS in renal transplant patients is that immunosuppressive therapy, 
particularly corticosteroids, has been associated with the cushingoid features such as weight 
gain, obesity, abnormal fat distribution and development of the metabolic syndrome. 
Brilakis et al. in a study in a population of 17 heart transplant recipients, found an average 
weight gain of 10,7 kg in 16 patients (Brilakis et al 2000) who were diagnosed with SAS. In 
another study on cardiac transplant patients, SAS was diagnosed in 36 of 45 patients (80%) 
studied with polisomnography. In patients with SAS, weight gain was greater that in 
patients without SAS (Javaheri et al. 2004).   
 
 
Figure. The possible causal relationships between the different sleep disturbances and the 
phatogenethical mechanisms is outlined. RLS: Restless Legs Syndrome; PLMD: Periodic 
Limbs Movement Disorder; SAS: Sleep apnea Syndrome; EDS: Excessive Daytime 
Sleepiness. Modified from Parker et al., 2003.  
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The clinical presentation of sleep apnea in ESRD patients is similar to that observed in 
patients without chronic renal failure, namely the presence of loud snoring and witnessed 
apneas during sleep, nocturnal awakenings, and excessive daytime sleepiness. However, 
some of these symptoms may be mistakenly attributed to Chronic renal failure (CRF) itself, 
or to comorbid condition. This has led to the under-diagnosis and under-treatment of sleep 
apnea in this specific population. The presence of untreated SAS in this population, can 
exacerbate the symptoms of CRF, contributing to daytime fatigue and sleepiness and, may 
exacerbate the cardiovascular complications of ESRD, which are the most important cause of 
death in this population of patients.  
3. Conclusions 
In conclusion, sleep disorders are very common among dialysis patients and the 
pathogenethical mechanism that have been hypothesized are various (see Figure). These 
disorders play an important role among dialysis patients affecting both the quality of life 
(sleep disturbances are referred as to one of the most important distressing symptoms) and 
the mortality risk. The increased mortality risk among dialysis patients affected by sleep 
disturbances has been demonstrated by many epidemiological studies. In addition, recent 
studies have also confirmed the association between sleep disturbances, such as RLS, and 
vascular diseases . These data confirm once more the role of sleep in contributing to the 
increased vascular risk in dialysis patients. However, more studies are needed in order to 
better define the pathogenetical mechanism of sleep disorders.  
Nephrologists should became familiar with these disorders, promptly identify them in this 
group of patients and start a proper management in order to improve the quality of life and 
reduce the vascular risk.  
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